Literature DB >> 24899017

Multidermatomal herpes zoster.

Deepak Sundriyal1, Ruchi Kapoor2, Naveen Kumar3, Meenu Walia1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24899017      PMCID： PMC4054262          DOI： 10.1136/bcr-2014-205024

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Infection with varicella-zoster virus after marrow transplantation.

Authors:  R M Locksley; N Flournoy; K M Sullivan; J D Meyers
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

2.  Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.

Authors:  M J Keating; S O'Brien; S Lerner; C Koller; M Beran; L E Robertson; E J Freireich; E Estey; H Kantarjian
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

3.  Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate.

Authors:  Gloria N Mattiuzzi; Jorge E Cortes; Moshe Talpaz; James Reuben; Mary Beth Rios; Jianjin Shan; Dimitrios Kontoyiannis; Francis J Giles; Issam Raad; Srdan Verstovsek; Alessandra Ferrajoli; Hagop M Kantarjian
Journal:  Clin Cancer Res       Date:  2003-03       Impact factor: 12.531
  3 in total
  1 in total

Review 1.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.